Covered recipient · General Payments record
RAYMOND KIDWELL
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2018–2024
$2,283.12
- Reported across 123 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $521.21 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| UCB, Inc. | $136.80 | 6 |
| Incyte Corporation | $97.95 | 5 |
| Amgen Inc. | $84.37 | 4 |
| ABBVIE INC. | $74.57 | 4 |
| Galderma Laboratories, L.P. | $50.53 | 3 |
| LEO Pharma Inc. | $21.37 | 1 |
| Regeneron Healthcare Solutions, Inc. | $19.15 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $18.88 | 1 |
| Biofrontera Inc. | $17.59 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.74 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104068936 | CMS |
| ABBVIE INC. | $22.41 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104068938 | CMS |
| ABBVIE INC. | $23.05 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104068940 | CMS |
| ABBVIE INC. | $13.37 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104068942 | CMS |
| Amgen Inc. | $15.49 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117597978 | CMS |
| Amgen Inc. | $21.18 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117597980 | CMS |
| Amgen Inc. | $22.70 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117597982 | CMS |
| Amgen Inc. | $25.00 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117597984 | CMS |
| Biofrontera Inc. | $17.59 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107178690 | CMS |
| Galderma Laboratories, L.P. | $18.04 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145309048 | CMS |
| Galderma Laboratories, L.P. | $16.94 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145309050 | CMS |
| Galderma Laboratories, L.P. | $15.55 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145309052 | CMS |
| Incyte Corporation | $27.30 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141265303 | CMS |
| Incyte Corporation | $21.20 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141316669 | CMS |
| Incyte Corporation | $14.39 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141266667 | CMS |
| Incyte Corporation | $17.47 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141271846 | CMS |
| Incyte Corporation | $17.59 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141232689 | CMS |
| LEO Pharma Inc. | $21.37 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152637773 | CMS |
| Novartis Pharmaceuticals Corporation | $18.88 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087154856 | CMS |
| Regeneron Healthcare Solutions, Inc. | $19.15 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114086921 | CMS |
| UCB, Inc. | $19.89 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143194136 | CMS |
| UCB, Inc. | $7.49 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143194140 | CMS |
| UCB, Inc. | $27.25 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143194145 | CMS |
| UCB, Inc. | $39.36 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143194149 | CMS |
| UCB, Inc. | $11.98 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143194153 | CMS |
| UCB, Inc. | $30.83 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143194158 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.